Burning Rock Biotech Ltd expected to post a loss of CNY1.61 a share - Earnings Preview

Burning Rock Biotech

12/11/2021 14:51

* Burning Rock Biotech Ltd  BNR.OQ   BNR.O  is expected to show
a rise in quarterly revenue when it reports  results on November
16. 
* The Guangzhou, Guangdong-based company is expected to report 
a 4.1% increase in revenue to CNY129 million from CNY123.88
million a year ago, according to the estimate from one analyst,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Burning Rock Biotech
Ltd is for a loss of CNY1.61 per share. For the same quarter
last year, the company reported a loss of CNY1.22 per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Burning Rock
Biotech Ltd is $30.95​, about 53.3% above​ its last closing
price of $14.44. ​​​
This summary was machine generated November 12 at 14:51 GMT. 
All figures in Chinese yuan renminbi  unless otherwise stated